Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
46
NMPA:46
Drug Approvals
Clevidipine Injectable Emulsion
- Product Name
- 氯维地平乳状注射液
- Approval Number
- 国药准字H20244045
- Approval Date
- Jun 18, 2024
NMPA
Ceftriaxone Sodium and Tazobactam Sodium for Injection
- Product Name
- 注射用头孢曲松钠他唑巴坦钠
- Approval Number
- 国药准字H20227153
- Approval Date
- Nov 2, 2022
NMPA
Ceftriaxone Sodium and Tazobactam Sodium for Injection
- Product Name
- 注射用头孢曲松钠他唑巴坦钠
- Approval Number
- 国药准字H20227152
- Approval Date
- Nov 2, 2022
NMPA
Moxifloxacin Hydrochloride Injection
- Product Name
- 盐酸莫西沙星注射液
- Approval Number
- 国药准字H20130039
- Approval Date
- Oct 19, 2022
NMPA
Metformin Hydrochloride and Vildagliptin Tablets（Ⅲ）
- Product Name
- 二甲双胍维格列汀片(Ⅲ)
- Approval Number
- 国药准字H20223339
- Approval Date
- May 25, 2022
NMPA
Cefotaxime Sodium and Tazobactam Sodium for Injection
- Product Name
- 注射用头孢噻肟钠他唑巴坦钠
- Approval Number
- 国药准字H20210045
- Approval Date
- Oct 22, 2021
NMPA
Cefotaxime Sodium and Tazobactam Sodium for Injection
- Product Name
- 注射用头孢噻肟钠他唑巴坦钠
- Approval Number
- 国药准字H20210044
- Approval Date
- Oct 22, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
Clinical Trials
No trials found
News
No news found